Amisulpride
Side effects
Options:
Hide MedDRA Preferred Terms
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
Extrapyramidal disorder
|
Extrapyramidal disorder
|
11% - 33%
|
2%
|
|
x
|
x
|
x
|
x
|
Extrapyramidal symptoms
|
very common
|
|
x
|
|
|
|
|
Hypokinesia
|
Hypokinesia
|
very common
|
|
x
|
|
|
|
|
Akathisia
|
Akathisia
|
very common
|
|
x
|
|
|
|
|
Insomnia
|
Insomnia
|
common, 10% - 11%
|
7%
|
x
|
x
|
x
|
x
|
x
|
Anxiety
|
Anxiety
|
common, 7% - 9%
|
5%
|
x
|
x
|
x
|
x
|
x
|
Dyskinesia
|
Dyskinesia
|
very common, 2% - 6%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Movements involuntary
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Endocrine disorder
|
Endocrine disorder
|
common
|
|
x
|
x
|
x
|
x
|
x
|
Gastrointestinal disorder
|
Gastrointestinal disorder
|
common
|
|
x
|
x
|
x
|
x
|
x
|
Muscle rigidity
|
Muscle rigidity
|
very common, 2% - 5%
|
2%
|
x
|
x
|
x
|
x
|
x
|
Muscle spasms
|
Muscle spasms
|
common
|
|
x
|
|
|
|
|
Trismus
|
Trismus
|
common
|
|
x
|
|
|
|
|
Weight increased
|
Weight increased
|
common, 2% - 6%
|
5%
|
x
|
x
|
x
|
x
|
x
|
Agitation
|
Agitation
|
common, 5%
|
3%
|
x
|
x
|
x
|
x
|
x
|
Dystonia
|
Acute dystonia
|
common
|
|
x
|
|
|
|
|
Constipation
|
Constipation
|
common, 3% - 4%
|
1%
|
x
|
x
|
x
|
x
|
x
|
Tremor
|
Tremor
|
very common, 3% - 4%
|
6%
|
x
|
x
|
x
|
x
|
x
|
Somnolence
|
Somnolence
|
3% - 4%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Headache
|
Headache
|
3%
|
4%
|
|
x
|
x
|
x
|
x
|
Amenorrhoea
|
Amenorrhoea
|
0% - 4%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Nausea
|
Nausea
|
common, 2%
|
2%
|
x
|
x
|
x
|
x
|
x
|
Nervousness
|
Nervousness
|
2%
|
1%
|
|
x
|
x
|
x
|
x
|
Tension
|
Nervousness
|
2%
|
1%
|
|
x
|
x
|
x
|
x
|
Salivary hypersecretion
|
Salivary hypersecretion
|
very common, 2%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Vomiting
|
Vomiting
|
common, 2%
|
3%
|
x
|
x
|
x
|
x
|
x
|
Dry mouth
|
Dry mouth
|
common, 1% - 2%
|
1%
|
x
|
x
|
x
|
x
|
x
|
Galactorrhoea
|
Galactorrhoea
|
1% - 3%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Depression
|
Depression
|
1% - 2%
|
0%
|
|
x
|
x
|
x
|
x
|
Suicide attempt
|
Suicide attempt
|
1% - 2%
|
0%
|
|
x
|
x
|
x
|
x
|
Weight decreased
|
Weight decreased
|
1% - 2%
|
2%
|
|
x
|
x
|
x
|
x
|
Abdominal pain
|
Abdominal pain
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Gastrointestinal pain
|
Abdominal pain
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Diarrhoea
|
Diarrhoea
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Asthenia
|
Fatigue
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Fatigue
|
Fatigue
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Hypotension
|
Hypotension
|
common, 1%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Vaginal inflammation
|
Vaginal inflammation
|
1%
|
0%
|
|
x
|
x
|
x
|
x
|
Vaginal infection
|
Vaginal inflammation
|
1%
|
0%
|
|
x
|
x
|
x
|
x
|
Oculogyric crisis
|
Oculogyric crisis
|
common, 1%
|
0%
|
x
|
x
|
x
|
x
|
x
|
Aggression
|
Aggressive reaction
|
1%
|
1%
|
|
x
|
x
|
x
|
x
|
Cardiovascular disorder
|
Cardiovascular disorder
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Hyperglycaemia
|
Hyperglycaemia
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Hypersensitivity
|
Hypersensitivity
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Immune system disorder
|
Immune system disorder
|
uncommon
|
|
x
|
|
|
|
|
Bradycardia
|
Bradycardia
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Tardive dyskinesia
|
Tardive dyskinesia
|
uncommon
|
|
x
|
x
|
x
|
x
|
x
|
Dizziness
|
Dizziness
|
0% - 1%
|
1%
|
|
x
|
x
|
x
|
x
|
Dyspepsia
|
Dyspepsia
|
0% - 1%
|
0%
|
|
x
|
x
|
x
|
x
|
Hypertension
|
Hypertension
|
0% - 1%
|
0%
|
|
x
|
x
|
x
|
x
|
Orthostatic hypotension
|
Orthostatic hypotension
|
0% - 1%
|
0%
|
|
x
|
x
|
x
|
x
|
Menstrual disorder
|
Menstrual disorder
|
0% - 1%
|
0%
|
|
x
|
x
|
x
|
x
|
Pruritus
|
Pruritus
|
0% - 1%
|
1%
|
|
x
|
x
|
x
|
x
|
Skin disorder
|
Skin disorder
|
0% - 1%
|
1%
|
|
x
|
x
|
x
|
x
|
Unspecified disorder of skin and subcutaneous tissue
|
postmarketing
|
|
x
|
|
|
|
|
Hyperhidrosis
|
Sweating increased
|
0% - 1%
|
1%
|
|
x
|
x
|
x
|
x
|
Agranulocytosis
|
Agranulocytosis
|
postmarketing
|
|
x
|
|
|
x
|
x
|
Angioedema
|
Angioedema
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Sudden death
|
Sudden death
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Cardiac arrest
|
Cardiac arrest
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Cardiac disorder
|
Cardiac disorder
|
postmarketing
|
|
x
|
|
|
|
|
Leukopenia
|
Leukopenia
|
postmarketing
|
|
x
|
|
|
x
|
x
|
Nervous system disorder
|
Nervous system disorder
|
postmarketing
|
|
x
|
|
|
|
|
Central nervous system disorder
|
|
|
|
x
|
x
|
x
|
x
|
Neuroleptic malignant syndrome
|
Neuroleptic malignant syndrome
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Neutropenia
|
Neutropenia
|
postmarketing
|
|
x
|
|
|
x
|
x
|
Pregnancy
|
Pregnancy
|
postmarketing
|
|
x
|
|
|
|
|
Pulmonary embolism
|
Pulmonary embolism
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Torsade de pointes
|
Torsade de pointes
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Urticaria
|
Urticaria
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Angiopathy
|
Angiopathy
|
postmarketing
|
|
x
|
|
|
|
|
Ventricular fibrillation
|
Ventricular fibrillation
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Ventricular tachycardia
|
Ventricular tachycardia
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Ventricular arrhythmia
|
Ventricular arrhythmia
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Deep vein thrombosis
|
Deep vein thrombosis
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Drug withdrawal syndrome
|
Drug withdrawal syndrome
|
postmarketing
|
|
x
|
|
x
|
x
|
x
|
Embolism venous
|
Venous thromboembolism
|
postmarketing
|
|
x
|
x
|
x
|
x
|
x
|
Mental disorder
|
Mental disorder
|
|
|
x
|
x
|
x
|
x
|
x
|
Gynaecomastia
|
Gynaecomastia
|
|
|
x
|
x
|
x
|
x
|
x
|
Breast pain
|
Breast pain
|
|
|
x
|
x
|
x
|
x
|
x
|
Neuropathy peripheral
|
Neuropathy peripheral
|
|
|
|
x
|
x
|
x
|
x
|
Convulsion
|
Convulsion
|
|
|
x
|
x
|
x
|
x
|
x
|
Malnutrition
|
Malnutrition
|
|
|
x
|
x
|
x
|
x
|
x
|
Erectile dysfunction
|
Erectile dysfunction
|
|
|
x
|
x
|
x
|
x
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 60 |
Source: | Medsafe |
---|
Side effects: | 64 |
Source: | medicines.org.au |
---|
Side effects: | 65 |
Source: | medicines.org.au |
---|
Side effects: | 68 |
Source: | medicines.org.au |
---|
Side effects: | 68 |
Source: | medicines.org.au |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|